Programs
Rejuvenate Bio, two programs
Updated 1 Jan 2024OSK partial reprogramming gene therapyA harmless virus carries three Yamanaka factors into old animals; a common antibiotic switches them on to partly reprogram cells and reverse aging.ResearchNextBig-animal and disease studiesUpdated 1 Jan 2024View program →Canine mitral valve disease gene therapyA one-time gene therapy to slow heart-valve wear, the top cause of heart failure in small dogs.PilotNextVet study of whether it worksUpdated 22 Jun 2022View program →
Research · Proto · Pilot · Deploy · Scaling
Research & demos
- Jan 2024paperGene therapy-mediated partial reprogramming extends lifespan in aged mice (Cellular Reprogramming) (opens doi.org)OSK partial reprogramming gene therapy
Switching on three Yamanaka factors in very old mice roughly doubled their remaining lifespan.
- Nov 2019
One combined gene therapy improved obesity, diabetes, heart and kidney disease in mice.
Peers
Company & funding
- HQ
- US
People
- George Church (opens en.wikipedia.org)Co-founder
- Noah DavidsohnCo-founder and Chief Scientific Officer